Curis (CRIS) Long-Term Investments (2010 - 2021)
Curis (CRIS) reported Long-Term Investments of $24.0 million for Q4 2021, up 64.54% on a YoY basis from $14.6 million in Q4 2020, and up 14.54% quarter-over-quarter from $20.9 million in Q3 2021.
Curis (CRIS) Long-Term Investments (2010 - 2021) Analysis & Trends
Curis has reported Long-Term Investments for 11 years, with the latest figure at $24.0 million in Q4 2021.
- For the quarter ending Q4 2021, Long-Term Investments rose 64.54% year-over-year to $24.0 million; the trailing twelve-month figure through Dec 2021 stood at $24.0 million (up 64.54% YoY), and the FY2021 full-year result was $24.0 million, up 64.54% from the prior year.
- Long-Term Investments for Q4 2021 stood at $24.0 million, up from $20.9 million in the prior quarter.
- The five-year high for Long-Term Investments was $24.0 million in Q4 2021, with the low at $153000.0 in Q4 2017.
- Historically, Long-Term Investments has averaged $8.0 million across 4 years, with a median of $4.1 million in 2017.
- Annual changes were most pronounced in 2017 — Long-Term Investments changed 0.0% — and 2021, when it surged 64.54%.
- Curis' Long-Term Investments stood at $153000.0 in 2017, then changed by 0.0% to $153000.0 in 2018, then jumped by 9418.95% to $14.6 million in 2020, then surged by 64.54% to $24.0 million in 2021.
- The last three Long-Term Investments figures came in at $24.0 million (Q4 2021), $20.9 million (Q3 2021), and $8.1 million (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 23.96 Mn |
| Sep 30, 2021 | 20.92 Mn |
| Jun 30, 2021 | 8.11 Mn |
| Mar 31, 2021 | 11.94 Mn |
| Dec 31, 2020 | 14.56 Mn |
| Dec 31, 2018 | 153,000.00 |
| Sep 30, 2018 | 153,000.00 |
| Jun 30, 2018 | 153,000.00 |
| Mar 31, 2018 | 153,000.00 |
| Dec 31, 2017 | 153,000.00 |
| Dec 31, 2016 | 153,000.00 |
| Sep 30, 2016 | 153,000.00 |
| Jun 30, 2016 | 153,000.00 |
| Mar 31, 2016 | 152,610.00 |
| Dec 31, 2015 | 153,000.00 |
| Sep 30, 2015 | 152,610.00 |
| Jun 30, 2015 | 152,610.00 |
| Mar 31, 2015 | 7.20 Mn |
| Dec 31, 2014 | 788,768.00 |
| Sep 30, 2014 | 152,610.00 |